Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice

Science(2021)10.1126/science.abf6840Source: DataRank Database

Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice is a research paper published in Science (2021). On theSindex it has a DataRank of 0. It has been cited 465 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access465 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 23.04)OA: hybridTopics (37)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Priyanthi N.P. Gnanapragasam,Yu E. Lee ORCID,Pauline R. Hoffman ORCID,Susan Ou ORCID,Leesa M. Kakutani ORCID

Live enrichment

PubMed:33436524 PMC:PMC7928838 OpenAlex:https://openalex.org/W3119412259

National Institutes of Health

Grant: P01-AI138938-S1

NIAID NIH HHS

Grant: P01 AI138938

Medical Research Council

Grant: MR/P001351/1

Caltech Merkin Institute for Translational Research

George Mason University Fast Grant

Howard Hughes Medical Institute

FWCI

23.04

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1126/science.abf6840

publisherhttps://doi.org/10.1126/science.abf6840

publisherhttps://syndication.highwire.org/content/doi/10.1126/science.abf6840

publisherhttps://www.science.org/doi/pdf/10.1126/science.abf6840

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33436524

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studiesImmune responses and vaccinations

MeSH Terms

Protein DomainsBetacoronavirusCOVID-19SARS-CoV-2COVID-19 VaccinesViral ZoonosesAnimalsAntibodies, ViralCross ReactionsEnzyme-Linked Immunosorbent AssayFemaleImmunoglobulin GImmune SeraImmunizationMice, Inbred BALB CNeutralization TestsReceptors, Antigen, B-CellCoronavirus InfectionsMiceNanoparticlesAntibodies, NeutralizingSpike Glycoprotein, Coronavirus

Keywords

VirologyCoronavirusImmune systemCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Biology2019-20 coronavirus outbreakCoronavirus InfectionsImmunologyMedicineOutbreakInfectious disease (medical specialty)

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies

10.6084/m9.figshare.21085242.v1figshare

Additional file 1 of A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies

10.6084/m9.figshare.21085242figshare